RAPT Therapeutics (NASDAQ:RAPT) reported its Q1 earnings results on Thursday, May 11, 2023 at 08:00 AM.
Here’s what investors need to know about the announcement.
Earnings
RAPT Therapeutics missed estimated earnings by 11.76%, reporting an EPS of $-0.76 versus an estimate of $-0.68.
Revenue was down $641 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.02 which was followed by a 3.3% drop in the share price the next day.
Here’s a look at RAPT Therapeutics’s past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.66 | -0.67 | -0.75 | -0.68 |
| EPS Actual | -0.64 | -0.63 | -0.62 | -0.69 |
| Revenue Estimate | 220K | 340K | 280K | 220K |
| Revenue Actual | 0 | 0 | 886K | 641K |
Listen to the earnings announcement yourself by clicking here.
To track all earnings releases for RAPT Therapeutics visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
